- Home
- AUGO vs RLAY Comparison
AUGO vs RLAY Comparison
Compare AUGO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUGO | RLAY |
|---|---|---|
| Founded | 1946 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.1B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AUGO | RLAY |
|---|---|---|
| Price | $84.91 | $19.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $67.60 | $19.50 |
| AVG Volume (30 Days) | 891.3K | ★ 2.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.97% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $91.05 | N/A |
| Revenue Next Year | $17.09 | $324.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $29.11 | $3.89 |
| 52 Week High | $110.32 | $21.27 |
Technical Indicators
Market Signals| Indicator | AUGO | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 63.59 | 43.70 |
| Support Level | $78.80 | $18.02 |
| Resistance Level | $91.24 | $20.82 |
| Average True Range (ATR) | 4.12 | 0.87 |
| MACD | -0.59 | -0.24 |
| Stochastic Oscillator | 81.69 | 21.00 |
Price Performance
Historical ComparisonAbout AUGO Aura Minerals Inc.
Aura Minerals Inc is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The company's operating segments include: Minosa Mine, Apoena Mine, the Aranzazu Mine, Almas Mine, Borborema Mine and Serra Grande Mine. It derives maximum revenue from Aranzazu Mine. The company's growth projects include: Matupa in Brazil, and Era Dorada in Guatemala. whereas its exploration projects include: Carajas, in Brazil, and Tolda Fria in Colombia.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.